{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:25Z","timestamp":1792786105972,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100014865","name":"French Foundation for Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Bettencourt-Schueller \u2018Poste CCA-Bettencourt\u2019","id":[{"id":"https:\/\/ror.org\/02p3abx23","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the demographic, clinical, serological, genetic background, course and value of the interferon (IFN) score in a cohort of patients with rheumatoid factor (RF)-positive polyarticular juvenile idiopathic arthritis (pJIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Monocentric retrospective study of patients with RF-positive pJIA. Demographic, clinical and laboratory data were collected. The IFN score was calculated based on the expression levels of 24 IFN stimulated genes. Whole exome sequencing was performed in 22 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-two patients were included. The IFN score was positive in 18 patients (56.2%) and negative in 14 patients (43.7%). An increased IFN score was associated with a significantly higher family history of autoimmunity (P\u2009=\u20090.0004), parental first-degree consanguinity (P\u2009=\u20090.05) and prevalence of antibodies to anti-cyclic citrullinated peptide (ACPA) (P\u2009=\u20090.01). Three patients with interstitial lung disease exhibited a positive IFN score. Conversely, demographic features and characteristics of polyarthritis did not differ between the two groups. Clinically inactive disease was achieved in 21\/32 (66%) patients, with no significant difference according to the IFN score. Remission was never achieved with methotrexate alone. We identified one patient with a pathogenic de novo mutation in COPA. Additionally, ultra-rare variants in genes related to IFN and\/or innate immunity were found in 21\/22 (95.5%) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The IFN signature identified two distinct subgroups in RF-positive pJIA according to family history and immunological features. Our study suggests that patients with an elevated IFN score should be screened for pulmonary involvement. Future prospective studies are required to validate the use of the IFN score as a biomarker in RF-positive pJIA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag486","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:34:04Z","timestamp":1788867244000},"source":"Crossref","is-referenced-by-count":0,"title":["Interferon-driven gene signature identifies two distinct subgroups in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis"],"prefix":"10.1093","volume":"65","author":[{"given":"Anna","family":"Agrusti","sequence":"first","affiliation":[{"name":"University of Genoa Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), , Genoa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"David","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Bichat-Claude Bernard, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]},{"name":"Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Breton","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology-Haematology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP , Paris,","place":["France"]},{"name":"Reference Center for Rheumatic, AutoImmune, Interferonopathies and Systemic Diseases in Children (RAISE) , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-333X","authenticated-orcid":false,"given":"Isabelle","family":"Melki","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]},{"name":"Department of General Pediatrics, Armand Trousseau Hospital, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-549X","authenticated-orcid":false,"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology-Haematology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP , Paris,","place":["France"]},{"name":"Reference Center for Rheumatic, AutoImmune, Interferonopathies and Systemic Diseases in Children (RAISE) , Paris,","place":["France"]},{"name":"Laboratory of Immunogenetics of Paediatric Autoimmunity, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Dumaine","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Infectious Disease and Pediatric Rheumatology, Robert Debr\u00e9 Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloise","family":"Reumaux","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jeanne de Flandre Hospital , Lille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Jurquet","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, APHM, Marseille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Fournier","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology-Haematology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP , Paris,","place":["France"]},{"name":"Reference Center for Rheumatic, AutoImmune, Interferonopathies and Systemic Diseases in Children (RAISE) , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Seabra","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4223-0571","authenticated-orcid":false,"given":"Gillian I","family":"Rice","sequence":"additional","affiliation":[{"name":"Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology-Haematology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP , Paris,","place":["France"]},{"name":"Laboratory of Immunogenetics of Paediatric Autoimmunity, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-9141","authenticated-orcid":false,"given":"Marie-Louise","family":"Fr\u00e9mond","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Inserm U 1163, Paris-cit\u00e9 University , Paris,","place":["France"]},{"name":"Department of Paediatric Immunology-Haematology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP , Paris,","place":["France"]},{"name":"Reference Center for Rheumatic, AutoImmune, Interferonopathies and Systemic Diseases in Children (RAISE) , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026100720421293800_keag486-B1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2026100720421293800_keag486-B2","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2026100720421293800_keag486-B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-023-01125-6","article-title":"Role of IFN-\u03b1 in Rheumatoid Arthritis","volume":"26","author":"Lin","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"2026100720421293800_keag486-B4","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2665-9913(21)00254-X","article-title":"The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease","volume":"4","author":"Cooles","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2026100720421293800_keag486-B5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaci.2017.08.026","article-title":"The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy","volume":"141","author":"Cooles","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026100720421293800_keag486-B6","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3389\/fimmu.2017.02007","article-title":"Heterogeneity of the type I interferon signature in rheumatoid arthritis: a potential limitation for its use as a clinical biomarker","volume":"8","author":"Rodr\u00edguez-Carrio","year":"2018","journal-title":"Front Immunol"},{"key":"2026100720421293800_keag486-B7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ard.2025.03.007","article-title":"Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis","volume":"84","author":"Kartawinata","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026100720421293800_keag486-B8","doi-asserted-by":"crossref","first-page":"e2451341","DOI":"10.1001\/jamanetworkopen.2024.51341","article-title":"Genetic Association of juvenile idiopathic arthritis with adult rheumatic disease","volume":"7","author":"Fan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026100720421293800_keag486-B9","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S2665-9913(19)30142-0","article-title":"Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts","volume":"2","author":"Belot","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2026100720421293800_keag486-B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-020-00425-w","article-title":"Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype","volume":"18","author":"Clarke","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026100720421293800_keag486-B11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12887-022-03716-1","article-title":"A toddler with an unusually severe polyarticular arthritis and a lung involvement: a case report","volume":"22","author":"Basile","year":"2022","journal-title":"BMC Pediatr"},{"key":"2026100720421293800_keag486-B12","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1093\/rheumatology\/keaa763","article-title":"Rheumatoid factor positive polyarticular juvenile idiopathic arthritis associated with a novel COPA mutation","volume":"60","author":"Bader-Meunier","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026100720421293800_keag486-B13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12969-023-00860-5","article-title":"How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience","volume":"21","author":"Ozdel","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026100720421293800_keag486-B14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026100720421293800_keag486-B15","doi-asserted-by":"publisher","first-page":"e20200600","DOI":"10.1084\/jem.20200600","article-title":"Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling","volume":"217","author":"Lepelley","year":"2020","journal-title":"J Exp Med"},{"key":"2026100720421293800_keag486-B16","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026100720421293800_keag486-B17","doi-asserted-by":"crossref","first-page":"e67633","DOI":"10.1371\/journal.pone.0067633","article-title":"WW domain containing E3 ubiquitin protein ligase 1 (WWP1) negatively regulates TLR4-mediated TNF-\u03b1 and IL-6 production by proteasomal degradation of TNF receptor associated factor 6 (TRAF6)","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"2026100720421293800_keag486-B18","doi-asserted-by":"crossref","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2026100720421293800_keag486-B19","doi-asserted-by":"crossref","first-page":"114114","DOI":"10.1016\/j.celrep.2024.114114","article-title":"Endothelial cell expression of a STING gain-of-function mutation initiates pulmonary lymphocytic infiltration","volume":"43","author":"Gao","year":"2024","journal-title":"Cell Rep"},{"key":"2026100720421293800_keag486-B20","doi-asserted-by":"crossref","first-page":"1671984","DOI":"10.3389\/fimmu.2025.1671984","article-title":"Case report: Novel UNC93B1 variant causes rheumatoid arthritis and interstitial pneumonia","volume":"16","author":"He","year":"2025","journal-title":"Front Immunol"},{"key":"2026100720421293800_keag486-B21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) among 21 patients","volume":"9","author":"Fr\u00e9mond","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026100720421293800_keag486-B22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/cells11030318","article-title":"Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)","volume":"11","author":"David","year":"2022","journal-title":"Cells"},{"key":"2026100720421293800_keag486-B23","doi-asserted-by":"crossref","first-page":"e7037","DOI":"10.1002\/rcr2.70378","article-title":"Rheumatoid arthritis-associated interstitial pneumonia refractory to initial therapy: successful control through combined anti-inflammatory, antifibrotic and JAK-STAT-targeted treatment","volume":"13","author":"Kodera","year":"2025","journal-title":"Respirol Case Rep"},{"key":"2026100720421293800_keag486-B24","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","article-title":"The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort","volume":"74","author":"Guzman","year":"201","journal-title":"Ann Rheum Dis"},{"key":"2026100720421293800_keag486-B25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa2405459","article-title":"Common diseases in clinical cohorts - not always what they seem","volume":"393","author":"Rahimov","year":"2025","journal-title":"N Engl J Med"},{"key":"2026100720421293800_keag486-B26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan","year":"2023","journal-title":"Lancet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag486\/71004247\/keag486.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/10\/keag486\/71004247\/keag486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/10\/keag486\/71004247\/keag486.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:20Z","timestamp":1791420140000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag486\/8788618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag486","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,8]]},"article-number":"keag486"}}